Pure Global AI
NCT06350799Completed

Chronic Obstructive Pulmonary Disease and Community Health Worker Home-visits

COPD Home-Visits: Community Health Worker Home-visit Support to Enhance Self-Management and Improve Quality of Life Among Rural Veterans With Chronic Obstructive Pulmonary Disease
VA Puget Sound Health Care SystemClinicalTrials.gov
Verified
Study focus
Disease/Condition
COPD
Study type
Observational
Sponsor & location
Primary sponsor
VA Puget Sound Health Care System
Location
Seattle, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 14, 2019
End date
Apr 28, 2023
Enrollment
9 participants
Primary outcome

Acceptability, Appropriateness, Feasibility

Summary

We examined a Community Health Worker (CHW) program for Chronic Obstructive Pulmonary Disease
 (COPD) in Veteran Participants. The goal of this study was to assess participants' perceived
 acceptability, appropriateness, and feasibility of the intervention, explore participants'
 COPD health outcomes, and gather insights from participants and CHWs to inform potential
 improvements.
 
 Veteran participants enrolled in the 12-week intervention and received a series of 9 CHW
 home, phone, or video visits. These visits provided education and chronic disease
 self-management practices to improve COPD health.
 
 Researchers examined the participant and CHW perception of the intervention through
 qualitative interviews and surveys.

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedPulmonary heart disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06350799
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06350799 through Pure Global AI's free database. This phase not specified trial is sponsored by VA Puget Sound Health Care System and is currently Completed. The study focuses on COPD. Target enrollment is 9 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.